| Dr Michael K Koehler, MD | |
|
8185 Washington St Ste 2, Chagrin Falls, OH 44023-4575 | |
| (440) 708-1515 | |
| (440) 708-1515 |
| Full Name | Dr Michael K Koehler |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 34 Years |
| Location | 8185 Washington St Ste 2, Chagrin Falls, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962419234 | NPI | - | NPPES |
| 0184812 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 35062965 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospitals Ahuja Medical Center | Beachwood, OH | Hospital |
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Primary Care Practices Inc | 3072417534 | 940 |
News Archive
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Kaiser Health News staff writer Mary Agnes Carey talks with Politico's Jennifer Haberkorn and KFF's Jackie Judd about recent events in Washington, including Senate consideration of amendments to a package of small business tax breaks that would repeal a provision of the health care law that requires businesses to submit a 1099 form to the Internal Revenue Service for yearly purchases of $600 or more from a vendor.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.
Nurses in Belgium who administer life-ending drugs in euthanasia and in cases without explicit patient request often act outside of the law, according to a study in CMAJ.
› Verified 6 days ago
| Entity Name | University Primary Care Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Kaiser Health News staff writer Mary Agnes Carey talks with Politico's Jennifer Haberkorn and KFF's Jackie Judd about recent events in Washington, including Senate consideration of amendments to a package of small business tax breaks that would repeal a provision of the health care law that requires businesses to submit a 1099 form to the Internal Revenue Service for yearly purchases of $600 or more from a vendor.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.
Nurses in Belgium who administer life-ending drugs in euthanasia and in cases without explicit patient request often act outside of the law, according to a study in CMAJ.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael K Koehler, MD 24701 Euclid Ave, Third Floor Billing Services, Euclid, OH 44117-1714 Ph: (440) 708-1555 | Dr Michael K Koehler, MD 8185 Washington St Ste 2, Chagrin Falls, OH 44023-4575 Ph: (440) 708-1515 |
News Archive
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Kaiser Health News staff writer Mary Agnes Carey talks with Politico's Jennifer Haberkorn and KFF's Jackie Judd about recent events in Washington, including Senate consideration of amendments to a package of small business tax breaks that would repeal a provision of the health care law that requires businesses to submit a 1099 form to the Internal Revenue Service for yearly purchases of $600 or more from a vendor.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.
Nurses in Belgium who administer life-ending drugs in euthanasia and in cases without explicit patient request often act outside of the law, according to a study in CMAJ.
› Verified 6 days ago
Dr. Robert B Cameron, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 8185 E Washington St, Suite 2, Chagrin Falls, OH 44023 Phone: 440-708-1555 Fax: 440-708-1515 | |
Dr. Eric Jb Shapiro, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8185 E Washington St, Suite 2, Chagrin Falls, OH 44023 Phone: 440-708-1555 Fax: 440-708-1515 | |
Jason De Roulet, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8185 E Washington St, Suite 2, Chagrin Falls, OH 44023 Phone: 440-708-1555 Fax: 440-708-1515 | |
Dr. Raymond William Rozman, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8185 E Washington St # 2, Chagrin Falls, OH 44023 Phone: 216-708-1555 Fax: 216-708-1515 | |
Dr. Gail Margaret White, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 18539 Haskins Rd, Chagrin Falls, OH 44023 Phone: 216-262-6225 | |
Hetty Carraway, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 217 Lake Meade Dr, Chagrin Falls, OH 44022 Phone: 443-858-0854 | |
Dr. Vincent William Dennis, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5695 Park Wood Cir, Chagrin Falls, OH 44022 Phone: 440-349-1583 |